NCT02192203View on ClinicalTrials.gov

A Safety Study to Investigate the Skin Sensitization Potential of MFC51123

PHASE1CompletedINTERVENTIONAL

Enrollment

227

Participants

Timeline

Start Date

April 1, 2014

Primary Completion Date

July 15, 2014

Study Completion Date

July 15, 2014

Conditions

Pain

Interventions

DRUG

Diclofenac + Menthol Gel

1% diclofenac, 3% menthol

DRUG

Diclofenac Only Gel

1% diclofenac, 0.09% menthol

DRUG

Menthol Only Gel

3% menthol

DRUG

Placebo Only Gel

0.09% menthol

Trial Locations (1)

07652

TKL Research Inc, Paramus

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY